stockrowCareDx, Inc. (CDNA) vs GeneDx Holdings Corp. (WGS)
- CareDx, Inc. CDNA 76.96 −10.37%
- GeneDx Holdings Corp. WGS 64.89 −6.42%
CareDx, Inc. and GeneDx Holdings Corp. are both Diagnostics & Research companies. CareDx, Inc. is the larger, with a market value of $4.0B against $1.9B — 2.1× the size. GeneDx Holdings Corp. has negative trailing earnings, so its P/E is not meaningful; CareDx, Inc. trades at 30.9×. CareDx, Inc. grew revenue faster over the last twelve months: 38.9% against 25.4%. CareDx, Inc. has the higher net margin (25.9% vs −23.4%) and the higher return on invested capital (33.6% vs −27.7%). Across the 18 metrics below, CareDx, Inc. leads on 11 and GeneDx Holdings Corp. on 7.
Valuation
Profitability
| Metric | CDNA | WGS | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 70.97% | 69.37% | 48.32% |
| Operating margin | 23.42% | (20.34%) | (5.68%) |
| Net margin | 25.86% | (23.40%) | (4.10%) |
| Free cash flow margin | 12.01% | (16.68%) | 0.00% |
| Return on equity | 33.04% | (40.80%) | 0.00% |
| Return on assets | 23.96% | (22.50%) | (6.05%) |
| Return on invested capital | 33.56% | (27.70%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack